BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 21, 2013
View Archived Issues
Inspiration and Ipsen close sale of hemophilia B product candidate
Read More
Kitasato Daiichi Sankyo files for approval of tetravalent combination vaccine in Japan
Read More
Robot-induced depression demonstrates construct validity as an experimental model
Read More
GlaxoSmithKline synthesizes new JAK3 inhibitors
Read More
KBP BioSciences patents new antibacterial agents
Read More
Beta Pharma presents new ALK/c-Met inhibitors
Read More
Pfizer divulges new tyrosine-protein kinase inhibitors
Read More
Researchers at Gerinda Therapeutics disclose novel protein kinase inhibitors
Read More
Thallion Pharmaceuticals and LFB Biotechnologies terminate collaboration
Read More
Treatment begins in AEZS-108 study in triple-negative breast cancer
Read More
Puma reaches SPA agreement for phase III trial in HER2-positive metastatic breast cancer
Read More
CEP-11981 demonstrates activity against urothelial carcinoma in mice
Read More
New Janus kinase inhibitors prepared at Almirall
Read More
NeurOp and Emory collaborate on cognitive and mental health disorders
Read More
New estrogen receptor ligands reported by Karo Bio
Read More
UCB files applications to extend approval for Cimzia in the U.S. and Europe
Read More
Array BioPharma and Genentech patent novel ERK inhibitors
Read More
Dacomitinib proves effective in bladder cancer models
Read More
Phosphagenics plans to advance oxycodone/TPM technology to clinical trials
Read More
Merck & Co. and Samsung Bioepis enter agreement
Read More
ProtAffin obtains promising preclinical data in cystic fibrosis
Read More
Intramuscular formulations of Leunase approved in Japan
Read More
Abraxane approved in Japan for additional indications
Read More
Japanese authorities approve additional formulation and indication for anti-herpes agent
Read More
Chelsea Therapeutics receives FDA guidance regarding resubmission of Northera NDA
Read More